Bloomage BioTechnology 

0
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jul 17
€0.00
Jul 16
€0.00
Jul 15
€0.00
Jun 14
€0.00
Jun 13
€0.00
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

4NovExpected
Q1 2026
Next
0.02
0.02
0.03
0.03
Expected EPS
0.016223315819441
Actual EPS
N/A

Financials

7.07%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
504.25MRevenue
35.67MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.
Show more...
CEO
Yan Zhao
Employees
3698
Country
Cayman Islands
ISIN
KYG1179M1078

Listings

0 Comments

Share your thoughts

FAQ

What is Bloomage BioTechnology stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Bloomage BioTechnology stocks are traded under the ticker BBU.STU.
When is the next Bloomage BioTechnology earnings date?
Bloomage BioTechnology is going to release the next earnings report on November 04, 2026.
What were Bloomage BioTechnology earnings last quarter?
BBU.STU earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.03 EUR resulting in a -51.93% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Bloomage BioTechnology revenue for the last year?
Bloomage BioTechnology revenue for the last year amounts to 504.25M EUR.
What is Bloomage BioTechnology net income for the last year?
BBU.STU net income for the last year is 35.67M EUR.
Does Bloomage BioTechnology pay dividends?
Yes, BBU.STU dividends are paid annual. The last dividend per share was 0 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Bloomage BioTechnology have?
As of September 08, 2026, the company has 3,698 employees.
In which sector is Bloomage BioTechnology located?
Bloomage BioTechnology operates in the Materials sector.
When did Bloomage BioTechnology complete a stock split?
Bloomage BioTechnology has not had any recent stock splits.
Where is Bloomage BioTechnology headquartered?
Bloomage BioTechnology is headquartered in Jinan, Cayman Islands.